why choose us

First received: December 13, 2022

Clinical Trial: Efficacy and Safety of SA58 Nasal Spray in Close Contact With COVID-19 People

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: COVID-19

Study Type: Interventional


Official Title: A Randomized, Single-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of Anti-COVID-19 Antibody SA58 Nasal Spray, Among Close Contact With COVID-19 People

Brief Summary: This is a randomized, single-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of SA58 nasal spray in close contact with COVID-19 people.

Read more